Delivery Order SPE2DR25D3103-SPE2DR26F9Y63
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,668.21 on June 16, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50 units. This firm fixed price contract, which was not set-aside, is set for completion by June 17, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical support services through the company's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $2,928.76 to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Meropenem 0.9% Saline solution (1 gram/50s) with performance completion by April 30, 2025. This competitive, non-set-aside award utilizes a firm fixed price structure and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Meropenem 2 gram vials, valued at $17,036.76 under a firm fixed-price arrangement. This non-set-aside competitive award was executed on December 16, 2025, with an ultimate completion date of December 17, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen's corporate headquarters is situated. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $11,205.36 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, an antibiotic pharmaceutical product. The delivery order, which carries an ultimate completion date of December 18, 2025, is a non-set-aside award issued under competitive procedures. Performance of this contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is...
- The Defense Logistics Agency awarded a delivery order valued at $4,175.33 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a critical antibiotic medication. This firm fixed-price, competitively awarded delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceuticals will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations....
- The Defense Logistics Agency awarded a delivery order valued at $11,537.13 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a broad-spectrum antibiotic used in military and federal healthcare systems. This firm fixed price, non-set-aside contract was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $10,310.23 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50s, an antibiotic medication used in military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 22, 2025, and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded a delivery order valued at $7,365.36 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a broad-spectrum antibiotic used in military and federal healthcare settings. The award, issued on August 14, 2025, with completion targeted for August 15, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance...
- The Defense Logistics Agency awarded a delivery order valued at $18,947.32 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50s, a pharmaceutical product to be delivered to the company's facility in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,464.22 firm-fixed-price contract is for the delivery of 1 gram vials of the antibiotic Meropenem in 0.9% sodium chloride solution. The contract has an ultimate completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9Y63Delivery Order
The Defense Logistics Agency awarded a $4,393.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Meropenem 0.9% sodium chloride solution (1 gram/50 mL). This is a non-set-aside competitive award with an ultimate completion date of January 21, 2026, and performance location in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's parent company, Cencora, Inc., which operates the pharmaceutical supply chain for federal healthcare procurement. This delivery order is executed under Cencora's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. Meropenem, a broad-spectrum antibiotic commonly used in acute care settings, represents a critical pharmaceutical commodity within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 1/19/26 |